REGENERON PHARMACEUTICALS, INC., ISSUER AND U.S. Bank National Association, TRUSTEE INDENTURE DATED AS OF AUGUST 12, 2020 DEBT SECURITIESIndenture • August 12th, 2020 • Regeneron Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of August 12, 2020, among REGENERON PHARMACEUTICALS, INC., a New York corporation (the “Company”), and U.S. Bank National Association, as trustee (the “Trustee”): WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
as Issuer and U.S. Bank National Association, as Trustee First Supplemental Indenture Dated as of August 12, 2020Supplemental Indenture • August 12th, 2020 • Regeneron Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
SUPPLEMENTAL INDENTURE (this “First Supplemental Indenture”), dated as of August 12, 2020, between REGENERON PHARMACEUTICALS, INC., a New York corporation (the “Company”), and U.S. Bank National Association, a national association, as Trustee (the “Trustee”).
